CSI Market
Sign In | Register

Clearmind Medicine Inc (CMND) Annual Income Statement

Annual · GAAP · USD millions
Access CMND quarterly income statements →
Quarterly income statement trends provide context on Clearmind Medicine Inc's margins, operating leverage, and earnings trajectory.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Oct 31 2025)
2025 		(Oct 31 2024) (Oct 31 2023) (Oct 31 2022) (Dec 31 2016)
Revenues
Total Revenue0.00
Costs & Expenses
Gross Profit0.00
Selling, Administration, Marketing0.00
Depreciation & Amortization0.00
Research and Development Expense0.00
Total operating costs including COS0.00
Operating income / -loss0.00
Interest Expense0.00
Net Interest Expense / -Income0.00
Revenue From Dividends0.00
Other loss / -income0.00
Total costs & expenses0.00
Income & Taxes
Income / -loss before income taxes-2.70
Income taxes expenses / -benefit0.07
Income after income taxes-2.75
Net income / -loss of other equity0.00
Income / -loss from continuing operations-2.75
Net income / -loss-3.86
Income / -loss to shareholder-2.75
EBIT-2.70
EBITD-2.70
EBITDA-2.69
Earnings Per Share
Basic EPS (excl. extra items)-303.50
Basic Net EPS-303.50
Basic shares outstanding (Mill. of Units)0.01
Diluted Net EPS-303.50
Diluted average shares (Mill. of Units)0.01
4 historic quarters locked

Sign in to unlock the full Clearmind Medicine Inc income statement history.

Sign In Create Free Account

About CMND Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.